ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
FibroBiologics
0.3372
-0.0307
-8.34%
成交量:
84.53萬
成交額:
29.45萬
市值:
1,735.10萬
市盈率:
-0.70
高:
0.3697
開:
0.3492
低:
0.3330
收:
0.3679
52周最高:
2.98
52周最低:
0.3181
股本:
5,145.61萬
流通股本:
3,206.59萬
量比:
1.01
換手率:
2.64%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.4850
每股收益(LYR):
-0.3395
淨資產收益率:
-1292.87%
總資產收益率:
-115.62%
市淨率:
138.81
市盈率(LYR):
-0.99
資料載入中...
總覽
公司
新聞資訊
公告
Fibrobiologics, Inc.盤中異動 早盤大幅拉昇7.80%報0.353美元
市场透视
·
11/05
FibroBiologics Inc:正準備提交Cyps317治療銀屑病的臨牀試驗新藥申請
美股速递
·
11/01
Fibrobiologics, Inc.盤中異動 早盤股價大跌5.50%
市场透视
·
10/14
FibroBiologics宣佈積極的IND申請進展更新,展示成纖維細胞球體在慢性複發性銀屑病治療中的潛力
美股速递
·
09/11
FibroBiologics宣佈骨髓類器官平台取得重大進展,助力開發癌症和免疫相關療法
美股速递
·
09/10
Fibrobiologics, Inc.盤中異動 股價大漲5.25%
市场透视
·
08/14
Fibrobiologics, Inc.盤中異動 急速跳水5.17%
市场透视
·
08/11
Fibrobiologics, Inc.盤中異動 早盤股價大漲6.21%報0.567美元
市场透视
·
08/08
Fibrobiologics, Inc.盤中異動 早盤快速跳水5.23%
市场透视
·
08/04
Fibrobiologics, Inc.盤中異動 早盤大幅下挫5.32%
市场透视
·
08/01
Fibrobiologics, Inc.盤中異動 下午盤大幅拉昇6.94%報0.649美元
市场透视
·
07/31
Fibrobiologics, Inc.盤中異動 早盤大幅拉昇6.35%
市场透视
·
07/28
Fibrobiologics, Inc.盤中異動 早盤大幅拉昇5.09%報0.690美元
市场透视
·
07/25
Fibrobiologics, Inc.盤中異動 早盤大幅下跌7.61%
市场透视
·
07/23
Fibrobiologics, Inc.盤中異動 大幅下挫5.15%報0.680美元
市场透视
·
07/18
Fibrobiologics, Inc.盤中異動 快速下跌5.31%報0.660美元
市场透视
·
07/16
Fibrobiologics, Inc.盤中異動 急速上漲5.06%報0.672美元
市场透视
·
07/15
Fibrobiologics, Inc.盤中異動 股價大跌5.38%
市场透视
·
07/12
Fibrobiologics, Inc.盤中異動 大幅下挫6.05%報0.620美元
市场透视
·
07/10
Fibrobiologics, Inc.盤中異動 早盤快速拉昇5.09%
市场透视
·
07/09
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/FBLG/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FBLG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBLG\",,,,,undefined,":{"symbol":"FBLG","market":"US","secType":"STK","nameCN":"FibroBiologics","latestPrice":0.3372,"timestamp":1763412470666,"preClose":0.3679,"halted":0,"volume":845334,"delay":0,"floatShares":32065900,"shares":51456077,"eps":-0.484982,"marketStatus":"交易中","change":-0.0307,"latestTime":"11-17 15:48:01 EST","open":0.3492,"high":0.3697,"low":0.333,"amount":294538.89719268,"amplitude":0.099755,"askPrice":0.3393,"askSize":100,"bidPrice":0.3361,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-0.484982,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1763413200000},"marketStatusCode":2,"adr":0,"listingDate":1706677200000,"exchange":"NASDAQ","adjPreClose":0.3679,"preHourTrading":{"tag":"盘前","latestPrice":0.3426,"preClose":0.3679,"latestTime":"08:47 EST","volume":24816,"amount":8724.51471408,"timestamp":1763387259749},"postHourTrading":{"tag":"盘后","latestPrice":0.3531,"preClose":0.3679,"latestTime":"19:59 EST","volume":86620,"amount":31144.55895,"timestamp":1763168368594},"volumeRatio":1.005969},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBLG\",,,,,undefined,":{"symbol":"FBLG","floatShares":32065900,"roa":"-115.62%","roe":"-1292.87%","lyrEps":-0.339497,"volumeRatio":1.005969,"shares":51456077,"dividePrice":0,"high":0.3697,"amplitude":0.099755,"preClose":0.3679,"low":0.333,"week52Low":0.3181,"pbRate":"138.81","week52High":2.98,"institutionHeld":0,"latestPrice":0.3372,"committee":-0.941748,"eps":-0.484982,"divideRate":0,"volume":845334,"delay":0,"ttmEps":-0.484982,"open":0.3492,"prevYearClose":2,"prevWeekClose":0.3679,"prevMonthClose":0.3933,"prevQuarterClose":0.5462,"fiveDayClose":0.3569,"twentyDayClose":0.4103,"sixtyDayClose":0.5886},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBLG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-10-31","symbol":"FBLG","fiscalQuarterEnding":"2025/09","expectedEps":-0.1,"name":null,"time":"盤後","type":"earning","dateTimestamp":1761883200000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2025-07-31","symbol":"FBLG","fiscalQuarterEnding":"2025/06","expectedEps":-0.11,"name":null,"time":"盤後","type":"earning","dateTimestamp":1753934400000,"reportTimeType":"post","actualEps":-0.12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBLG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBLG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1730437200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FBLG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FBLG","date":"2025-11-14","current":-0.758585,"percent":0.988372,"low":-68.573467,"twenty":-13.245174,"median":-4.04235,"eighty":-2.172619,"high":-0.740379,"avg":-8.197896,"sd":10.726621,"marketCap":17273805},"quantilePoints":[{"date":"2024-02-02","current":-68.573467,"twenty":-68.573467,"median":-68.573467,"eighty":-68.573467,"marketCap":568611190},{"date":"2024-02-09","current":-30.642544,"twenty":-58.777258,"median":-48.452053,"eighty":-34.01244,"marketCap":254087971},{"date":"2024-02-16","current":-50.313332,"twenty":-58.777258,"median":-50.313332,"eighty":-30.642544,"marketCap":417198153},{"date":"2024-02-23","current":-47.413654,"twenty":-56.896385,"median":-48.5892,"eighty":-33.338461,"marketCap":393154022},{"date":"2024-03-01","current":-25.741365,"twenty":-54.984165,"median":-48.491237,"eighty":-33.338461,"marketCap":424346408},{"date":"2024-03-08","current":-19.47356,"twenty":-53.244359,"median":-47.492024,"eighty":-25.717713,"marketCap":321021631},{"date":"2024-03-15","current":-20.892685,"twenty":-51.363486,"median":-37.245189,"eighty":-20.955758,"marketCap":344415920},{"date":"2024-03-22","current":-23.849198,"twenty":-50.446561,"median":-28.99678,"eighty":-20.813845,"marketCap":393154022},{"date":"2024-03-28","current":-23.159345,"twenty":-50.219289,"median":-25.741365,"eighty":-20.93999,"marketCap":381781799},{"date":"2024-04-05","current":-22.469492,"twenty":-49.216157,"median":-24.637601,"eighty":-21.160743,"marketCap":370409575},{"date":"2024-04-12","current":-22.311811,"twenty":-48.471645,"median":-23.652097,"eighty":-21.298713,"marketCap":367810209},{"date":"2024-04-19","current":-21.700799,"twenty":-48.064123,"median":-23.20862,"eighty":-21.030656,"marketCap":357737668},{"date":"2024-04-26","current":-23.021374,"twenty":-47.63309,"median":-22.804563,"eighty":-21.030656,"marketCap":379507354},{"date":"2024-05-03","current":-13.245174,"twenty":-47.445002,"median":-22.479347,"eighty":-20.675875,"marketCap":218346696},{"date":"2024-05-10","current":-17.22661,"twenty":-43.252224,"median":-22.05558,"eighty":-19.871704,"marketCap":283980674},{"date":"2024-05-17","current":-17.017594,"twenty":-36.598639,"median":-21.769784,"eighty":-19.221271,"marketCap":383406402},{"date":"2024-05-24","current":-16.310932,"twenty":-31.990502,"median":-21.661379,"eighty":-18.255477,"marketCap":367485289},{"date":"2024-05-31","current":-17.767522,"twenty":-29.984238,"median":-21.543118,"eighty":-17.827098,"marketCap":400302277},{"date":"2024-06-07","current":-14.972667,"twenty":-28.19741,"median":-21.306597,"eighty":-17.252609,"marketCap":337334178},{"date":"2024-06-14","current":-10.427133,"twenty":-26.746956,"median":-21.178482,"eighty":-16.659936,"marketCap":234923317},{"date":"2024-06-21","current":-7.769521,"twenty":-25.741365,"median":-20.932105,"eighty":-16.368618,"marketCap":175047318},{"date":"2024-06-28","current":-6.767471,"twenty":-25.694061,"median":-20.88283,"eighty":-16.302279,"marketCap":152471122},{"date":"2024-07-05","current":-6.143005,"twenty":-25.43783,"median":-20.64631,"eighty":-15.81876,"marketCap":138401898},{"date":"2024-07-12","current":-7.689204,"twenty":-24.673079,"median":-20.183123,"eighty":-14.136173,"marketCap":173237756},{"date":"2024-07-15","current":-7.514809,"twenty":-24.649427,"median":-20.094427,"eighty":-13.517924,"marketCap":169308652},{"date":"2024-08-02","current":-7.974576,"twenty":-24.625775,"median":-20.005732,"eighty":-13.175194,"marketCap":179667198},{"date":"2024-08-09","current":-4.080921,"twenty":-24.140907,"median":-19.700225,"eighty":-10.836667,"marketCap":79459622},{"date":"2024-08-16","current":-2.166861,"twenty":-23.730937,"median":-18.842837,"eighty":-9.439605,"marketCap":42190950},{"date":"2024-08-23","current":-2.546062,"twenty":-23.640271,"median":-18.638558,"eighty":-7.79743,"marketCap":49574366},{"date":"2024-08-30","current":-2.915474,"twenty":-23.407692,"median":-18.172694,"eighty":-7.552859,"marketCap":56767191},{"date":"2024-09-06","current":-3.368187,"twenty":-23.218475,"median":-17.767522,"eighty":-6.924314,"marketCap":65581972},{"date":"2024-09-13","current":-5.722296,"twenty":-23.104157,"median":-17.428613,"eighty":-6.143005,"marketCap":111418835},{"date":"2024-09-20","current":-5.722296,"twenty":-22.93465,"median":-17.22661,"eighty":-5.90745,"marketCap":111418835},{"date":"2024-09-27","current":-5.686079,"twenty":-22.765143,"median":-16.563311,"eighty":-5.873037,"marketCap":110713652},{"date":"2024-10-04","current":-4.798761,"twenty":-22.619289,"median":-16.368618,"eighty":-5.722296,"marketCap":93436681},{"date":"2024-10-11","current":-4.20118,"twenty":-22.481318,"median":-16.080185,"eighty":-5.265962,"marketCap":81801170},{"date":"2024-10-18","current":-6.012033,"twenty":-22.40642,"median":-15.807485,"eighty":-5.066768,"marketCap":117060295},{"date":"2024-10-25","current":-5.215258,"twenty":-22.209319,"median":-15.237992,"eighty":-5.131958,"marketCap":101546280},{"date":"2024-10-31","current":-5.342017,"twenty":-22.020102,"median":-13.586112,"eighty":-5.110228,"marketCap":104014418},{"date":"2024-11-08","current":-6.464746,"twenty":-21.866364,"median":-12.649071,"eighty":-5.128337,"marketCap":125875076},{"date":"2024-11-15","current":-5.477931,"twenty":-21.799349,"median":-10.768411,"eighty":-5.146445,"marketCap":97392141},{"date":"2024-11-22","current":-4.698155,"twenty":-21.716567,"median":-9.773622,"eighty":-5.018763,"marketCap":83528491},{"date":"2024-11-29","current":-5.107537,"twenty":-21.700799,"median":-9.003931,"eighty":-5.016064,"marketCap":90806907},{"date":"2024-12-06","current":-4.639671,"twenty":-21.661379,"median":-7.895306,"eighty":-4.997955,"marketCap":82488717},{"date":"2024-12-13","current":-4.425233,"twenty":-21.562828,"median":-7.720912,"eighty":-4.979847,"marketCap":78676213},{"date":"2024-12-20","current":-3.957367,"twenty":-21.543118,"median":-7.546517,"eighty":-4.853087,"marketCap":70358023},{"date":"2024-12-27","current":-4.50321,"twenty":-21.511582,"median":-7.203145,"eighty":-4.778145,"marketCap":80062578},{"date":"2025-01-03","current":-3.869642,"twenty":-21.385437,"median":-6.905845,"eighty":-4.698155,"marketCap":68798363},{"date":"2025-01-10","current":-4.065278,"twenty":-21.306597,"median":-6.609614,"eighty":-4.652603,"marketCap":72276579},{"date":"2025-01-17","current":-3.769263,"twenty":-21.298713,"median":-6.286711,"eighty":-4.50321,"marketCap":67013721},{"date":"2025-01-24","current":-3.157497,"twenty":-21.243525,"median":-6.193118,"eighty":-4.433031,"marketCap":56137148},{"date":"2025-01-31","current":-3.295638,"twenty":-21.050366,"median":-6.140899,"eighty":-4.36675,"marketCap":58593149},{"date":"2025-02-07","current":-3.157497,"twenty":-20.955758,"median":-6.004281,"eighty":-4.203103,"marketCap":56137148},{"date":"2025-02-14","current":-2.545732,"twenty":-20.888743,"median":-5.948653,"eighty":-4.068407,"marketCap":45260576},{"date":"2025-02-21","current":-2.447061,"twenty":-20.872975,"median":-5.908467,"eighty":-3.946872,"marketCap":43506290},{"date":"2025-02-28","current":-2.348389,"twenty":-20.794135,"median":-5.885273,"eighty":-3.784683,"marketCap":41752004},{"date":"2025-03-07","current":-2.210248,"twenty":-20.498484,"median":-5.867165,"eighty":-3.670591,"marketCap":39296004},{"date":"2025-03-14","current":-2.109947,"twenty":-20.183123,"median":-5.776622,"eighty":-3.453513,"marketCap":37512750},{"date":"2025-03-21","current":-2.151728,"twenty":-20.183123,"median":-5.722296,"eighty":-3.368187,"marketCap":38255577},{"date":"2025-03-28","current":-2.130838,"twenty":-20.005732,"median":-5.595537,"eighty":-3.295638,"marketCap":37884163},{"date":"2025-04-04","current":-2.958372,"twenty":-19.926892,"median":-5.518575,"eighty":-3.165965,"marketCap":33018387},{"date":"2025-04-11","current":-2.748074,"twenty":-19.788921,"median":-5.342017,"eighty":-3.105834,"marketCap":30671251},{"date":"2025-04-17","current":-3.685286,"twenty":-19.647008,"median":-5.282987,"eighty":-3.104326,"marketCap":41131477},{"date":"2025-04-25","current":-4.361485,"twenty":-19.501154,"median":-5.215258,"eighty":-3.131377,"marketCap":48678537},{"date":"2025-05-02","current":-3.496805,"twenty":-18.968982,"median":-5.142823,"eighty":-3.15355,"marketCap":39027837},{"date":"2025-05-09","current":-2.900977,"twenty":-18.732461,"median":-5.107537,"eighty":-3.105179,"marketCap":32377800},{"date":"2025-05-16","current":-5.090366,"twenty":-18.693381,"median":-5.090366,"eighty":-3.095239,"marketCap":39027837},{"date":"2025-05-23","current":-4.291877,"twenty":-18.607387,"median":-5.049055,"eighty":-3.101704,"marketCap":32905823},{"date":"2025-05-30","current":-3.742916,"twenty":-18.421041,"median":-5.00701,"eighty":-3.104523,"marketCap":28696939},{"date":"2025-06-06","current":-4.262932,"twenty":-18.227882,"median":-4.979847,"eighty":-3.124991,"marketCap":32683900},{"date":"2025-06-13","current":-4.354259,"twenty":-18.018955,"median":-4.934576,"eighty":-3.149603,"marketCap":33384106},{"date":"2025-06-20","current":-3.674878,"twenty":-17.856887,"median":-4.868731,"eighty":-3.157497,"marketCap":28175292},{"date":"2025-06-27","current":-3.644169,"twenty":-17.748258,"median":-4.815121,"eighty":-3.160884,"marketCap":27939844},{"date":"2025-07-03","current":-3.132347,"twenty":-17.688614,"median":-4.795627,"eighty":-3.157497,"marketCap":24015708},{"date":"2025-07-11","current":-3.321721,"twenty":-17.510817,"median":-4.711647,"eighty":-3.13343,"marketCap":25467638},{"date":"2025-07-18","current":-3.531568,"twenty":-17.278608,"median":-4.698155,"eighty":-3.14171,"marketCap":27076534},{"date":"2025-07-25","current":-3.36062,"twenty":-17.22661,"median":-4.675331,"eighty":-3.157497,"marketCap":25765873},{"date":"2025-08-01","current":-3.260303,"twenty":-17.184807,"median":-4.665775,"eighty":-3.157497,"marketCap":24996742},{"date":"2025-08-08","current":-1.692292,"twenty":-16.92818,"median":-4.639671,"eighty":-3.111465,"marketCap":22377179},{"date":"2025-08-15","current":-1.862725,"twenty":-16.567638,"median":-4.558872,"eighty":-3.098103,"marketCap":24630815},{"date":"2025-08-22","current":-1.865576,"twenty":-16.533025,"median":-4.524553,"eighty":-3.074912,"marketCap":24668515},{"date":"2025-08-29","current":-1.964732,"twenty":-16.426305,"median":-4.50321,"eighty":-3.015849,"marketCap":25979645},{"date":"2025-09-05","current":-1.881416,"twenty":-16.368618,"median":-4.425233,"eighty":-2.962429,"marketCap":24877961},{"date":"2025-09-12","current":-1.789547,"twenty":-16.310932,"median":-4.376497,"eighty":-2.933582,"marketCap":23663176},{"date":"2025-09-19","current":-1.694826,"twenty":-16.29651,"median":-4.361485,"eighty":-2.897365,"marketCap":22410690},{"date":"2025-09-26","current":-1.709716,"twenty":-15.863859,"median":-4.348021,"eighty":-2.853034,"marketCap":22607569},{"date":"2025-10-03","current":-1.710666,"twenty":-15.863859,"median":-4.327761,"eighty":-2.748074,"marketCap":22620136},{"date":"2025-10-10","current":-1.544034,"twenty":-15.807485,"median":-4.261494,"eighty":-2.486529,"marketCap":20416767},{"date":"2025-10-17","current":-1.298839,"twenty":-15.630094,"median":-4.210794,"eighty":-2.348389,"marketCap":17174548},{"date":"2025-10-24","current":-1.301056,"twenty":-15.503317,"median":-4.186877,"eighty":-2.318853,"marketCap":17203870},{"date":"2025-10-31","current":-1.257339,"twenty":-14.972667,"median":-4.132817,"eighty":-2.297962,"marketCap":16625800},{"date":"2025-11-07","current":-0.932278,"twenty":-13.927049,"median":-4.072247,"eighty":-2.249717,"marketCap":17248077},{"date":"2025-11-14","current":-0.933669,"twenty":-13.245174,"median":-4.04235,"eighty":-2.172619,"marketCap":17273805}],"updateTime":1763370392195},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBLG\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581854970","title":"Fibrobiologics, Inc.盤中異動 早盤大幅拉昇7.80%報0.353美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581854970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581854970?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 22:32","pubTimestamp":1762353155,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日22时32分,Fibrobiologics, Inc.股票出现波动,股价大幅上涨7.80%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体跌幅为0.47%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105223235a48adf60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105223235a48adf60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"1153706268","title":"FibroBiologics Inc:正準備提交Cyps317治療銀屑病的臨牀試驗新藥申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1153706268","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153706268?lang=zh_tw&edition=fundamental","pubTime":"2025-11-01 04:34","pubTimestamp":1761942866,"startTime":"0","endTime":"0","summary":"FibroBiologics Inc:正准备提交Cyps317治疗银屑病的临床试验新药申请","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2575242576","title":"Fibrobiologics, Inc.盤中異動 早盤股價大跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575242576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575242576?lang=zh_tw&edition=fundamental","pubTime":"2025-10-14 22:05","pubTimestamp":1760450730,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日22时05分,Fibrobiologics, Inc.股票出现异动,股价急速下跌5.50%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体跌幅为0.22%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014220530a6b9217f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014220530a6b9217f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"1179889476","title":"FibroBiologics宣佈積極的IND申請進展更新,展示成纖維細胞球體在慢性複發性銀屑病治療中的潛力","url":"https://stock-news.laohu8.com/highlight/detail?id=1179889476","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179889476?lang=zh_tw&edition=fundamental","pubTime":"2025-09-11 20:31","pubTimestamp":1757593879,"startTime":"0","endTime":"0","summary":"FibroBiologics宣布积极的IND申请进展更新,展示成纤维细胞球体在慢性复发性银屑病治疗中的潜力","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"1119399927","title":"FibroBiologics宣佈骨髓類器官平台取得重大進展,助力開發癌症和免疫相關療法","url":"https://stock-news.laohu8.com/highlight/detail?id=1119399927","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119399927?lang=zh_tw&edition=fundamental","pubTime":"2025-09-10 20:31","pubTimestamp":1757507478,"startTime":"0","endTime":"0","summary":"FibroBiologics宣布骨髓类器官平台取得重大进展,助力开发癌症和免疫相关疗法","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2559986796","title":"Fibrobiologics, Inc.盤中異動 股價大漲5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559986796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559986796?lang=zh_tw&edition=fundamental","pubTime":"2025-08-14 03:16","pubTimestamp":1755112581,"startTime":"0","endTime":"0","summary":"北京时间2025年08月14日03时16分,Fibrobiologics, Inc.股票出现波动,股价急速拉升5.25%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体涨幅为1.29%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508140316219745f7b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508140316219745f7b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2558666991","title":"Fibrobiologics, Inc.盤中異動 急速跳水5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558666991","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558666991?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 21:54","pubTimestamp":1754920448,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时54分,Fibrobiologics, Inc.股票出现异动,股价大幅下挫5.17%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体涨幅为0.24%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811215408a6dfc1b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811215408a6dfc1b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2557852773","title":"Fibrobiologics, Inc.盤中異動 早盤股價大漲6.21%報0.567美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557852773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557852773?lang=zh_tw&edition=fundamental","pubTime":"2025-08-08 21:36","pubTimestamp":1754660216,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时36分,Fibrobiologics, Inc.股票出现异动,股价大幅拉升6.21%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体跌幅为0.10%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080821365794d7cad2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080821365794d7cad2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2557338784","title":"Fibrobiologics, Inc.盤中異動 早盤快速跳水5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557338784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557338784?lang=zh_tw&edition=fundamental","pubTime":"2025-08-04 23:28","pubTimestamp":1754321293,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日23时28分,Fibrobiologics, Inc.股票出现异动,股价急速下跌5.23%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体涨幅为1.00%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080423281494cf1c9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080423281494cf1c9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2556812117","title":"Fibrobiologics, Inc.盤中異動 早盤大幅下挫5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556812117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556812117?lang=zh_tw&edition=fundamental","pubTime":"2025-08-01 22:02","pubTimestamp":1754056947,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日22时02分,Fibrobiologics, Inc.股票出现波动,股价快速下挫5.32%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体跌幅为0.20%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080122022794c91682&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080122022794c91682&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2555702692","title":"Fibrobiologics, Inc.盤中異動 下午盤大幅拉昇6.94%報0.649美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555702692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555702692?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 01:43","pubTimestamp":1753897409,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日01时43分,Fibrobiologics, Inc.股票出现波动,股价大幅上涨6.94%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体涨幅为0.63%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731014330a46bf6eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731014330a46bf6eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2554773777","title":"Fibrobiologics, Inc.盤中異動 早盤大幅拉昇6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554773777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554773777?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 21:33","pubTimestamp":1753709580,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时33分,Fibrobiologics, Inc.股票出现波动,股价大幅上涨6.35%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体涨幅为0.15%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213300a467da13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213300a467da13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2554953167","title":"Fibrobiologics, Inc.盤中異動 早盤大幅拉昇5.09%報0.690美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554953167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554953167?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 22:36","pubTimestamp":1753454209,"startTime":"0","endTime":"0","summary":"北京时间2025年07月25日22时36分,Fibrobiologics, Inc.股票出现异动,股价急速拉升5.09%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体跌幅为0.41%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072522364994bacb34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072522364994bacb34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2553424567","title":"Fibrobiologics, Inc.盤中異動 早盤大幅下跌7.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553424567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553424567?lang=zh_tw&edition=fundamental","pubTime":"2025-07-23 21:35","pubTimestamp":1753277754,"startTime":"0","endTime":"0","summary":"北京时间2025年07月23日21时35分,Fibrobiologics, Inc.股票出现异动,股价急速下跌7.61%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体涨幅为0.63%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723213554a45f1042&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723213554a45f1042&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2552743699","title":"Fibrobiologics, Inc.盤中異動 大幅下挫5.15%報0.680美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552743699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552743699?lang=zh_tw&edition=fundamental","pubTime":"2025-07-18 02:15","pubTimestamp":1752776149,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日02时15分,Fibrobiologics, Inc.股票出现波动,股价急速下挫5.15%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体跌幅为0.06%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071802155097aa14c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071802155097aa14c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2551112542","title":"Fibrobiologics, Inc.盤中異動 快速下跌5.31%報0.660美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551112542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551112542?lang=zh_tw&edition=fundamental","pubTime":"2025-07-16 21:49","pubTimestamp":1752673746,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时49分,Fibrobiologics, Inc.股票出现异动,股价快速跳水5.31%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体涨幅为0.59%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716214906a44ee72d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716214906a44ee72d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2551198880","title":"Fibrobiologics, Inc.盤中異動 急速上漲5.06%報0.672美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551198880","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551198880?lang=zh_tw&edition=fundamental","pubTime":"2025-07-15 21:47","pubTimestamp":1752587265,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日21时47分,Fibrobiologics, Inc.股票出现波动,股价快速拉升5.06%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071521474595438d0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071521474595438d0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2550966552","title":"Fibrobiologics, Inc.盤中異動 股價大跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550966552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550966552?lang=zh_tw&edition=fundamental","pubTime":"2025-07-12 03:01","pubTimestamp":1752260512,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日03时01分,Fibrobiologics, Inc.股票出现异动,股价快速跳水5.38%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体跌幅为0.66%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712030152a6a45a3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712030152a6a45a3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2550066624","title":"Fibrobiologics, Inc.盤中異動 大幅下挫6.05%報0.620美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550066624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550066624?lang=zh_tw&edition=fundamental","pubTime":"2025-07-10 23:38","pubTimestamp":1752161888,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日23时38分,Fibrobiologics, Inc.股票出现波动,股价急速下跌6.05%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710233808953d9e3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710233808953d9e3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2550529653","title":"Fibrobiologics, Inc.盤中異動 早盤快速拉昇5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550529653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550529653?lang=zh_tw&edition=fundamental","pubTime":"2025-07-09 21:44","pubTimestamp":1752068642,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时44分,Fibrobiologics, Inc.股票出现异动,股价快速上涨5.09%。Fibrobiologics, Inc.股票所在的生物技术行业中,整体涨幅为1.14%。Fibrobiologics, Inc.公司简介:FibroBiologics Inc 是一家临床阶段细胞治疗公司,专注开发和商业化基于成纤维细胞的治疗方法,用于治疗患有严重未满足医疗需求的慢性疾病的患者,包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用,包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214402a4407f27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214402a4407f27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}]}}